Patents by Inventor Herbert Moessler

Herbert Moessler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200376040
    Abstract: Disclosed is cerebrolysin for use in reducing mortality in CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) patients.
    Type: Application
    Filed: August 28, 2018
    Publication date: December 3, 2020
    Inventors: Stefan WINTER, Herbert MÖSSLER
  • Publication number: 20110160141
    Abstract: The present invention relates to a neurotrophic peptide having an amino acid sequence of VGDGGLFEKKL (SEQ ID NO:1), EDQQVHFTPTEG (SEQ ID NO:2) or IPENEADGMPATV (SEQ ID NO:3), and comprising an adamantyl group at the C- and/or N-terminal end.
    Type: Application
    Filed: March 9, 2011
    Publication date: June 30, 2011
    Inventors: Herbert Mössler, Khalid Iqbal, Inge Grundke-Iqbal
  • Publication number: 20090048172
    Abstract: The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
    Type: Application
    Filed: January 26, 2005
    Publication date: February 19, 2009
    Inventors: Herbert Moessler, Christa Riedl, Wolfgang Schmitzberger, Heinz Schnait
  • Patent number: 7151088
    Abstract: The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: December 19, 2006
    Assignee: Ebewe Pharma Ges.M.H. Nfg.KG
    Inventors: Herbert Moessler, Christa Riedl, Wolfgang Schmitzberger, Heinz Schnait
  • Patent number: 7148192
    Abstract: The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
    Type: Grant
    Filed: January 29, 2004
    Date of Patent: December 12, 2006
    Assignee: Ebwe Pharma Ges. M.H. Nfg.KG
    Inventors: Herbert Moessler, Christa Riedl, Wolfgang Schmitzberger, Heinz Schnait
  • Publication number: 20060035812
    Abstract: The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
    Type: Application
    Filed: September 21, 2005
    Publication date: February 16, 2006
    Inventors: Herbert Moessler, Christa Riedl, Wolfgang Schmitzberger, Heinz Schnait
  • Publication number: 20050227922
    Abstract: The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.
    Type: Application
    Filed: January 29, 2004
    Publication date: October 13, 2005
    Inventors: Herbert Moessler, Christa Riedl, Wolfgang Schmitzberger, Heinz Schnait